Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Endocrinology

Pharmacology/kinetics

Cardiovascular outcomes with ertugliflozin in type 2 diabetes

New England Journal of Medicine | Oct 12, 2020 Pharmacology/kinetics

Dapagliflozin in patients with chronic kidney disease

New England Journal of Medicine | Oct 12, 2020 Pharmacology/kinetics

More severe erosive phenotype despite lower circulating autoantibody levels in dipeptidyl peptidase-4 inhibitor (DPP4i)-associated bullous pemphigoid: a retrospective cohort study

American Journal of Clinical Dermatology | Oct 10, 2020 Pharmacology/kinetics

The impact of empagliflozin on obstructive sleep apnea, cardiovascular, and renal outcomes: An exploratory analysis of the EMPA-REG OUTCOME Trial

Diabetes Care | Oct 07, 2020 Pharmacology/kinetics

Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: Combined post hoc analysis of the SUSTAIN and PIONEER trials

Cardiovascular Diabetology | Oct 07, 2020 Pharmacology/kinetics

Major adverse cardiovascular and limb events in patients with diabetes and concomitant peripheral artery disease treated with sodium glucose cotransporter 2 inhibitor vs dipeptidyl peptidase-4 inhibitor

Cardiovascular Diabetology | Oct 07, 2020 Pharmacology/kinetics

Efficacy and safety of endothelin receptor antagonists in type 2 diabetic kidney disease: A systematic review and meta‐analysis of randomized controlled trials

Diabetic Medicine | Oct 07, 2020 Pharmacology/kinetics

Systemic corticosteroids and mortality in severe and critical COVID-19 patients in Wuhan, China

Journal of Clinical Endocrinology & Metabolism | Oct 07, 2020 Pharmacology/kinetics

Lower cardiorenal risk with sodium‐glucose cotransporter‐2 inhibitors vs dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study

Diabetes, Obesity and Metabolism | Oct 07, 2020 Pharmacology/kinetics

Statin therapy and risk of polyneuropathy in type 2 diabetes: A Danish cohort study

Diabetes Care | Oct 05, 2020 Pharmacology/kinetics

« Prev 1 … 22 23 24 25 26 … 122 Next »

Cardiovascular outcomes with ertugliflozin in type 2 diabetes

Dapagliflozin in patients with chronic kidney disease

More severe erosive phenotype despite lower circulating autoantibody levels in dipeptidyl peptidase-4 inhibitor (DPP4i)-associated bullous pemphigoid: a retrospective cohort study

The impact of empagliflozin on obstructive sleep apnea, cardiovascular, and renal outcomes: An exploratory analysis of the EMPA-REG OUTCOME Trial

Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: Combined post hoc analysis of the SUSTAIN and PIONEER trials

Major adverse cardiovascular and limb events in patients with diabetes and concomitant peripheral artery disease treated with sodium glucose cotransporter 2 inhibitor vs dipeptidyl peptidase-4 inhibitor

Efficacy and safety of endothelin receptor antagonists in type 2 diabetic kidney disease: A systematic review and meta‐analysis of randomized controlled trials

Systemic corticosteroids and mortality in severe and critical COVID-19 patients in Wuhan, China

Lower cardiorenal risk with sodium‐glucose cotransporter‐2 inhibitors vs dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study

Statin therapy and risk of polyneuropathy in type 2 diabetes: A Danish cohort study

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

The Role of Nutrition in Enhancing Fertility for Men and Women

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

More Women Experience Chronic Pain Than Men: Find Out Why

Cardiovascular outcomes with ertugliflozin in type 2 diabetes

Dapagliflozin in patients with chronic kidney disease

More severe erosive phenotype despite lower circulating autoantibody levels in dipeptidyl peptidase-4 inhibitor (DPP4i)-associated bullous pemphigoid: a retrospective cohort study

The impact of empagliflozin on obstructive sleep apnea, cardiovascular, and renal outcomes: An exploratory analysis of the EMPA-REG OUTCOME Trial

Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: Combined post hoc analysis of the SUSTAIN and PIONEER trials

Major adverse cardiovascular and limb events in patients with diabetes and concomitant peripheral artery disease treated with sodium glucose cotransporter 2 inhibitor vs dipeptidyl peptidase-4 inhibitor

Efficacy and safety of endothelin receptor antagonists in type 2 diabetic kidney disease: A systematic review and meta‐analysis of randomized controlled trials

Systemic corticosteroids and mortality in severe and critical COVID-19 patients in Wuhan, China

Lower cardiorenal risk with sodium‐glucose cotransporter‐2 inhibitors vs dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study

Statin therapy and risk of polyneuropathy in type 2 diabetes: A Danish cohort study

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

The Role of Nutrition in Enhancing Fertility for Men and Women

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

More Women Experience Chronic Pain Than Men: Find Out Why

Select Specialty

Select Topic